Beta-blocker therapy for heart failure: should the therapeutic target be dose or heart rate reduction?

Congestive heart failure (Greenwich, Conn.)

Volumn 12, Issue 4, 2006, Pages

  Huang, Robert L ^a   Listerman, Jennifer ^a   Goring, Joann ^a   Giesberg, Carrie ^a   Nading, Mary Alice ^a   Butler, Javed ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAZOLE DERIVATIVE; CARVEDILOL; METOPROLOL; PROPANOLAMINE DERIVATIVE;

ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DRUG EFFECT; FEMALE; HEART RATE; HUMAN; MALE; MIDDLE AGED; MORTALITY; SURVIVAL RATE; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; CARBAZOLES; FEMALE; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; MALE; METOPROLOL; MIDDLE AGED; PROPANOLAMINES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33750139630     PISSN: 15275299     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-5299.2006.05477.x     Document Type: Article

References (0)